Onderneming Rhythm Pharmaceuticals, Inc.
Aandelen
RYTM
US76243J1051
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,15 USD | +3,43% | +1,10% | -12,03% |
Vakgebied
Aantal werknemers: 226
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics
100,0
%
| 24 | 100,0 % | 77 | 100,0 % | +227,56% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
80,6
%
| 24 | 100,0 % | 62 | 80,6 % | +164,09% |
Other
11,5
%
| - | - | 9 | 11,5 % | - |
Germany
7,8
%
| - | - | 6 | 7,8 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 01-11-15 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 01-07-17 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 27-07-20 |
Dana Washburn
CTO | Chief Tech/Sci/R&D Officer | 61 | 26-09-22 |
David Connolly
IRC | Investor Relations Contact | - | 01-05-19 |
Comptroller/Controller/Auditor | 53 | 01-03-23 | |
Corporate Officer/Principal | - | 01-04-21 | |
Pamela Cramer
HRO | Human Resources Officer | 50 | 26-07-21 |
Jim Flaherty
LAW | General Counsel | - | 01-07-19 |
Yann Mazabraud
PRN | Corporate Officer/Principal | 51 | 05-10-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 01-04-15 |
Jennifer Good
BRD | Director/Board Member | 59 | 19-06-19 |
David McGirr
BRD | Director/Board Member | 69 | 01-11-15 |
Director/Board Member | 71 | 09-12-20 | |
Director/Board Member | 64 | 21-03-13 | |
David Meeker
CEO | Chief Executive Officer | 69 | 01-11-15 |
Lynn Tetrault
BRD | Director/Board Member | 61 | 09-12-20 |
Stuart Arbuckle
BRD | Director/Board Member | 58 | 24-07-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 60 972 909 | 57 367 172 ( 94,09 %) | 0 | 94,09 % |
Bedrijfsgegevens
Rhythm Pharmaceuticals, Inc.
222 Berkeley Street 12th floor
02116-3748, Boston
+857 264 4280
http://www.rhythmtx.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,03% | 2,37 mld. | |
-3,14% | 102 mld. | |
+1,50% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,72% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,64% | 16,36 mld. | |
+5,07% | 13,97 mld. | |
+32,90% | 12,17 mld. |
- Beurs
- Aandelen
- Koers RYTM
- Onderneming Rhythm Pharmaceuticals, Inc.